ACQUIRED · 2020
Who Acquired NN Life Sciences (Paragon Medical)?
American Securities · $825.0M· 12.5× EBITDA
The acquisition
NN Life Sciences (Paragon Medical) was acquired by American Securities in 2020 for $825.0M. The deal was priced at 12.5× EBITDA / 2.40× revenue.
NN Life Sciences (Paragon Medical) at time of acquisition
Revenue
$338.8M
EBITDA
$66.0M
Deal value
$825.0M
EV / EBITDA
12.5×
Other acquisitions by American Securities
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- SimonMed · 2021 · $600.0M · 8.0× EBITDA
Similar medical devices acquisitions
- Owen Mumford Holdings · acquired by Embecta in 2026 · $201.0M
- Acera Surgical · acquired by Solventum in 2025 · $725.0M
- Alydia Health (Organon JADA System) · acquired by Laborie Medical Technologies in 2025 · $440.0M
- B Medical Systems (Azenta) · acquired by THELEMA S.A. R.L. in 2025 · $63.0M
- BIOTRONIK Vascular Intervention Business · acquired by Teleflex, Inc. in 2025 · $875.9M
Run a valuation for a similar medical devices business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical devices calculator →More on medical devices valuations
- Medical Devices valuation calculator· head-term variant
- Medical Devices median multiples· real-deal benchmarks
- How to value a medical devices· long-form guide
Sourced from Press releases and investor presentations. Full deal page.
Citation: ExitValue.ai. (2020). NN Life Sciences (Paragon Medical) acquired by American Securities. https://exitvalue.ai/acquired/nn-life-sciences-paragon-medical